Given these promising results, translating the use of neoadjuvant immunotherapy in pMMR tumors with microsatellite instability features conferred by high tumor mutation burden and POLE mutations offers other potential treatment possibilities; however, more research is needed.21, 22. The gene discussed is POLE; the disease is neoplasm.